WHO statement: Tobacco use and COVID-19 Tobacco kills more than 8 million people globally every year. More than 7 million of these deaths are from direct tobacco use and around 1.2 million are due to non-smokers being exposed to second-hand smoke…

COVID-19: Versorgung von Patienten mit Lebererkrankungen  Die Deutsche Leberstiftung hat die deutsche Übersetzung des Positionspapiers der EASL (European Association for the Study of the Liver) und der ESCMID (European Society of Clinical Micr…

Update. Coronavirus und Drogenhilfe – Erhebung und Dokumentation der Situation in „harten“ Drogenszenen - Aufruf an alle Mitarbeiter*innen der ambulanten Drogenhilfe in Deutschland Womöglich haben Sie schon von unserer seit dem 31.3. laufenden…

Mitigating the Psychological Impact of COVID-19 on Healthcare Workers: A Digital Learning Package. Blake H, Bermingham F, Johnson G, Tabner A. Int J Environ Res Public Health. 2020 Apr 26;17(9). pii: E2997. doi: 10.3390/ijerph17092997. https://ww…

Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program. Peavy, K.M., Darnton, J., Grekin, P. et al.  AIDS Behav (2020)…

USA. How Are Opioid Treatment Programs Combatting COVID-19?  Mark W. Parrino, M.P.A. – AATOD, 01.05.2020 http://www.aatod.org/2020/05/how-are-opioid-treatment-programs-combatting-covid-19